Regeneron Pharmaceuticals shares owned by New England Research & Management
Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by New England Research & Management
from 13F filings
Historical chart of New England Research & Management investment in Regeneron Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Regeneron Pharmaceuticals held by New England Research & Management consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Regeneron Pharmaceuticals by New England Research & Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $386k | 500 | 771.87 |
| 2025-06-30 | $318k | 605 | 525.62 |
| 2025-03-31 | $384k | 605 | 634.71 |
| 2023-06-30 | $675k | 940 | 718.09 |
| 2022-09-30 | $642k | 932 | 688.84 |
| 2022-06-30 | $586k | 991 | 591.32 |
| 2022-03-31 | $661k | 946 | 698.73 |
| 2021-12-31 | $616k | 975 | 631.79 |
| 2021-09-30 | $372k | 615 | 604.88 |
| 2021-06-30 | $927k | 1.7k | 558.43 |
| 2021-03-31 | $880k | 1.9k | 473.12 |
| 2020-12-31 | $548k | 1.1k | 482.82 |
| 2020-09-30 | $898k | 1.6k | 559.50 |
| 2016-12-31 | $268k | 730 | 367.12 |
| 2016-09-30 | $344k | 855 | 402.34 |
| 2016-06-30 | $400k | 1.1k | 349.35 |
| 2016-03-31 | $351k | 975 | 360.00 |
| 2013-12-31 | $688k | 2.5k | 275.42 |
More positions owned by New England Research & Management
View all positions for New England Research & Management